<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
OCX
OncoCyte
$
()


  • OncoCyte appoints Andrea James to CFO

    6/17/2024 - 16:09pm
  • OncoCyte announces VitaGraft Kidney data published in NEJM

    5/30/2024 - 16:50pm
  • OncoCyte reports Q1 EPS ($1.13), consensus (67c)

    5/15/2024 - 16:18pm
  • OncoCyte files to sell 5.42M shares of common stock for holders

    5/10/2024 - 17:39pm
  • Biotech Alert: Searches spiking for these stocks today

    4/15/2024 - 10:45am
  • Fly Intel: Pre-market Movers

    4/12/2024 - 08:55am
  • OncoCyte reports Q4 revenue $314,000, consensus $320,000

    4/12/2024 - 06:06am
  • OncoCyte to sell 5.077M shares at $ 2.92 in private placement

    4/12/2024 - 05:11am
  • Fly Intel: After-Hours Movers

    4/11/2024 - 18:23pm
  • OncoCyte, BioRad to partner on global launch of GraftAssure assay

    4/11/2024 - 17:31pm
  • Two new option listings and option delistings on February 26th

    2/26/2024 - 08:30am
  • Biotech Alert: Searches spiking for these stocks today

    1/5/2024 - 11:01am
  • OncoCyte begins FDA submissions process for VitaGraft transplant assays

    12/6/2023 - 08:06am
  • OncoCyte reports Q3 EPS (81c), consensus ($1.01)

    11/9/2023 - 07:04am
  • OncoCyte presents clinical data on VitaGraft Kidney

    9/18/2023 - 08:25am
dynamic_feed Breaking News